Viewing StudyNCT00217594



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217594
Status: COMPLETED
Last Update Posted: 2018-10-30
First Post: 2005-09-20

Brief Title: A Pilot Study of Alemtuzumab CampathR in Patients With Myelodysplastic Syndrome
Sponsor: National Heart Lung and Blood Institute NHLBI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Keywords:
Name View
Monoclonal Antibody Therapy View
Immunosuppression View
T Cells View
Hematopoiesis View
Anti-CD52 View